Entera Bio Ltd.
NASDAQ:ENTX
1.72 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current Assets: | |||||||||
| Cash & Cash Equivalents
| 11.019 | 12.309 | 24.892 | 8.593 | 15.185 | 7.506 | 11.746 | 4.163 | 1.205 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 4.015 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 11.019 | 12.309 | 24.892 | 8.593 | 15.185 | 11.521 | 11.746 | 4.163 | 1.205 |
| Net Receivables
| 0 | 0.54 | 0.183 | 0.516 | 0.278 | 0.725 | 0 | 0 | 0 |
| Inventory
| 0 | -0.294 | 0 | -0.093 | 0.076 | 0.13 | 0 | 0 | 0 |
| Other Current Assets
| 0.238 | 0.294 | 0.254 | 0.093 | 0.097 | 0.09 | 0.159 | 0.157 | 0.16 |
| Total Current Assets
| 11.257 | 12.849 | 25.329 | 9.109 | 15.636 | 12.466 | 12.417 | 5.433 | 1.9 |
| Non-Current Assets: | |||||||||
| Property, Plant & Equipment, Net
| 0.488 | 0.139 | 0.395 | 0.192 | 0.462 | 0.224 | 0.207 | 0.199 | 0.193 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0.605 | 0.605 | 0.651 | 0.654 | 0.654 | 0.654 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0.605 | 0.605 | 0.651 | 0.654 | 0.654 | 0.654 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0.014 | 0.043 | 0.217 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.006 | 0.096 | 0.046 | 0.356 | -1.067 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets
| 0.508 | 0.278 | 0.658 | 1.153 | 1.067 | 0.875 | 0.861 | 0.853 | 0.847 |
| Total Assets
| 11.765 | 13.127 | 25.987 | 10.262 | 16.703 | 13.341 | 13.278 | 6.286 | 2.747 |
| Liabilities & Equity: | |||||||||
| Current Liabilities: | |||||||||
| Account Payables
| 0.083 | 1.341 | 0.166 | 1.841 | 0.334 | 0.473 | 0.596 | 0.053 | 0.351 |
| Short Term Debt
| 0.134 | 0.091 | 0.179 | 0.189 | 0.177 | 0 | 0 | 9.885 | 0 |
| Tax Payables
| 0 | 0 | 0.134 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0.043 | 0.015 | 1.432 | 0.267 | 0.225 | 0 | 0 | 0 |
| Other Current Liabilities
| 0.874 | -0.134 | 2.801 | -0.189 | 3.814 | 1.09 | 1.424 | 0.604 | 0.453 |
| Total Current Liabilities
| 1.091 | 1.341 | 3.161 | 3.273 | 4.592 | 1.788 | 2.02 | 10.542 | 0.804 |
| Non-Current Liabilities: | |||||||||
| Long Term Debt
| 0.256 | 0 | 0.123 | 0.243 | 0.122 | 0 | 3.893 | 4.835 | 8.053 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.032 | 0.032 | 0.138 | 0.081 | 0.07 | 1.437 | 38.923 | 16.155 | 19.577 |
| Total Non-Current Liabilities
| 0.288 | 0.032 | 0.261 | 0.324 | 0.192 | 1.437 | 42.816 | 20.99 | 27.63 |
| Total Liabilities
| 1.379 | 1.373 | 3.422 | 3.597 | 4.784 | 3.225 | 44.836 | 31.532 | 28.434 |
| Equity: | |||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings
| -104.386 | -95.497 | -82.426 | -72.895 | -62.912 | -52.117 | -41.813 | -30.616 | -29.417 |
| Accumulated Other Comprehensive Income/Loss
| 0.041 | 0.041 | 0.041 | 8.965 | 11.439 | 13.06 | 7.402 | 2.885 | 1.395 |
| Other Total Stockholders Equity
| 114.73 | 107.21 | 104.95 | 70.595 | 63.392 | 49.173 | 2.853 | 2.485 | 2.335 |
| Total Shareholders Equity
| 10.386 | 11.754 | 22.565 | 6.665 | 11.919 | 10.116 | -31.558 | -25.246 | -25.687 |
| Total Equity
| 10.386 | 11.754 | 22.565 | 6.665 | 11.919 | 10.116 | -31.558 | -25.246 | -25.687 |
| Total Liabilities & Shareholders Equity
| 11.765 | 13.127 | 25.987 | 10.262 | 16.703 | 13.341 | 13.278 | 6.286 | 2.747 |